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Abstract Several bladder cancer culture systems have
been developed in recent years. However, reports about
successful primary cultures of superWcial urothelial carci-
nomas (UC) are sparse. Based on the speciWc growth
requirements of UC described previously, we developed a
new and reliable culture system for superWcial low-grade
UC. Between November 2002 and April 2006, 64 primary
cultures of bladder cancer specimens were performed. After
incubating the specimens overnight in 0.1% ethylenedi-
aminetetraacetic acid solution, tumour cells could easily be
separated from the submucosal tissue. Subsequently, cells
were seeded in a low-calcium culture medium supple-
mented with 1% serum, growth factors, non-essential
amino acids and glycine. The malignant origin of the cul-
tured cells was demonstrated by spectral karyotyping.
Overall culture success rate leading to a homogenous
tumour cell population without Wbroblast contamination
was 63%. Culture success could be remarkably enhanced
by the addition of glycine to the culture medium. Interest-
ingly, 86.4% of pTa tumours were cultured successfully
compared to only 50% of the pT1 and 38% of advanced
stage tumours, respectively. G1 and G2 tumours grew sig-
niWcantly better than G3 tumours (86, 73 and 41%, respec-
tively). Up to three passages of low-grade UC primary
cultures were possible. We describe a new and reliable cul-
ture system, which is highly successful for primary culture
and passage of low-grade UC of the bladder. Therefore, this
culture system can widely be used for functional experi-
ments on early stage bladder cancer.
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Introduction
SuperWcial low-grade urothelial carcinomas (UC) of the
bladder correspond to 70% of all UC and are characterised
by multiple recurrence in up to 50–70% of the cases. There-
fore, a reliable tumour model system would be extremely
useful for testing chemotherapeutics preventing cancer
recurrence. Besides animal models, analysis of UC is
almost exclusively employed on immortal cell lines [1–3].
Unfortunately, cell lines established from papillary UC like
RT4 or RT112, which represent an often-used model for
superWcial UC to date [4, 5], exhibit quite similar genetic
alterations as advanced bladder cancer cell lines [6]. Cell
lines derived from advanced UC carry typical molecular
and chromosomal alterations like loss of chromosomes 3p,
8p, 9 and 13q; gain of 5p, 6p, 8q and 20q; and mutations of
p53 and other tumour suppressors [7–10]. To solve the lim-
itations of cancer cell lines, several primary culture systems
of UC have been studied using tumour tissue pieces [11–
15] or urinary exfoliated cells [16, 17]. However, the
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advanced bladder cancer specimens and there were only
few reports about the short-term culture of low-grade
superWcial UC.
Recently, we observed substantial diVerences in the
mechanisms that drive proliferation of normal urothelial
cells and established UC cell lines [18]. Our Wndings sup-
port the assumption that the growth requirements of super-
Wcial low-grade UC resemble those of normal urothelial
cells, rather than those of advanced cancers. Based on our
Wndings, we modiWed the culture system described for nor-
mal urothelial cells by Southgate et al. [19] allowing us to
culture superWcial low-grade UC under almost serum-free
conditions.
Materials and methods
Media and chemicals
Dulbecco Minimum Essential Medium (DMEM) and
Keratinocyte serum free medium (KSFM) were purchased
from Gibco Life Technologies (Gaithersburg, MD, USA).
Serum-free EpiLife-medium and coating matrix was from
Cascade Biologics (Portland, OR, USA). Bovine pituitary
extracts, epidermal growth factor, insulin, transferrine,
selenium (ITS) as well as non-essential amino acids were
products from Gibco. All other chemicals, if not speciWed
diVerently, were products of Sigma-Aldrich (St. Louis,
MO, USA).
Patients and tissue specimens
Between November 2002 and April 2006, 64 primary cul-
tures of UC specimens were performed from patients who
underwent transurethral resection. After establishing an
optimised culture procedure, a series of 46 UC primary cul-
tures was analysed prospectively regarding culture success
and passage rate. Median age of these patients was 72 years
(range 52–95 years). Thirty-Wve patients were males and 11
were females. The study was approved by the ethics com-
mittee of the Heinrich-Heine University. Twenty-two UC
were staged as pTa, 8 as pT1 and 16 tumours as at least pT2
according to the UICC 1997 classiWcation. G1, G2 and G3
grading was found in 7, 22 and 17 patients, respectively.
Preparation of tumour pieces and primary culture
The specimens were stored in room temperature in Hank’s
Balanced Solution (HBSS). Under stereomicroscopic con-
trol, the specimens were freed from thermally damaged
parts and incubated overnight at 4°C in 0.1% ethylenedi-
aminetetraacetic acid (EDTA) solution containing 10 mM
HEPES and 20 kIU/ml aprotinin. The following day,
tumour cell layers were stripped from the submucosal tis-
sue using Pasteur pipettes (Fig. 1a–d). After washing in the
medium and pelleting for 5 min at 1,000£g, the tumour
cells were resuspended in fresh medium and plated in
75 cm2 culture Xasks (T-75) precoated with a culture
matrix. At this stage, most of the cells were present as clus-
ters of 10–100 cells.
Cell culture and passage
Approximately 100,000 cells were seeded in a T-75 Xask.
Cells were routinely grown in keratinocyte media with a
series of supplements (Table 1). Routinely, 20 ml medium
was used per T-75 Xask. Cultures were grown in a humidi-
Wed atmosphere of 5% CO2 in air at 37°C. When the pri-
mary cultures reached subconXuence (3–7 days after
seeding), the cells were detached using accutase I (PAA
Laboratories, Pasching, Austria). Cells were pelleted by
centrifugation and washed twice with medium before resee-
ding. Culture success and passage success were deWned if
more than 30% cell conXuence was reached.
Cell culture of human bladder Wbroblasts
Human bladder Wbroblasts were prepared using selective
culture conditions [20]. Bladder Wbroblasts were main-
tained in DMEM supplemented with 30% FBS. Condi-
tioned medium from the human bladder Wbroblast cultures
was added to the culture medium (Table 1).
Viability assay (MTT test)
Cell viability was determined by the Cell Titer-Glo Lumi-
nescent Cell Viability Assay (Promega, Mannheim, Ger-
many) according to the manufacturer’s instructions. Results
were based on three diVerent experiments.
Detection of cytokeratin
Immunohistochemical detection of cytokeratin 7 and 13
using FITC-conjugated antibodies (Sigma-Aldrich) was
performed to demonstrate the urothelial origin of the
tumour cells, as described earlier [18].
Cytogenetic analysis
Chromosome banding analysis of Wrst passage cultures of
three tumours (pTaG2, pT1G2 and pT4aG3) were per-
formed essentially as reported [21]. Multicolour karyo-
typing was done using a spectral karyotyping system
(Applied Spectral Imaging, Mannheim, Germany) as
described [22].123
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For statistical analysis, Fisher’s exact test and chi-square
test were performed using SPSS 11.5 for Windows (SPSS,
Chicago, IL, USA). A P-value of 0.05 or less was consid-
ered statistically signiWcant.
Results
After overnight treatment in 0.1% EDTA solution, the
tumour layers could easily be stripped from the submucco-
sal tissue (Fig. 1a–d). The EDTA treatment and very low-
serum concentration of 1% led to a homogenous tumour
Fig. 1 Preparation technique of 
the tumour specimens for prima-
ry culture. Using two Pasteur 
pipettes (a, small arrows, £3) 
the tumour cell layers of a 
superWcial UC (b, small arrows, 
£14) were gently stripped from 
the submucosal tissue under 
stereomicroscopic control; 
c shows the tumour specimen of 
b after almost all tumour cell 
layers have been removed. The 
obtained tumour tissue pieces 
(d, small arrows, £14) were 
then washed with medium, 
pelleted and resuspended in 
culture Xasks. e–f After process-
ing the tumour cell layers, 
»100,000 cells per 75 ml culture 
Xask were seeded. 12 h after 
seeding, the attached tumour 
cells started proliferation 
(e, £250, pTa G2 UC). About 
24 h after seeding, a monolayer 
of tumour cells was established. 
ConXuence was reached after  
3–7 days (f, day 6, £100, pTa 
G1 UC). g–h Immunohisto-
chemical detection of 
cytokeratin 7 (g) and 13 (h) was 
performed to demonstrate the 
urothelial origin of the tumour 
cells (£400, pTaG2 UC 
passage 1)
Table 1 Supplemented medium used for primary cultures of superW-
cial low-grade UC
Epilife Base 
medium
Bovine pituitary extracts (BPE) 25 g/ml
Epidermal growth factor (EGF) 0.5 ng/ml
Glycine 3 mM
MEM-non essential amino acids 1% (v/v)
Insulin, transferrine, selenium (ITS) 1% (v/v)
Supernatant human bladder Wbroblasts culture 10% (v/v)
Foetal calf serum (FCS) 1% (v/v)
Penicillin 100 U/ml
Streptomycin 100 g/ml123
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(Fig. 1e, f). Initial cultures were attempted in a completely
serum-free medium. However, we found that the addition
of Wbroblast-conditioned media evidently improves the
proliferation and survival of the cultures. The urothelial ori-
gin of the cells was demonstrated by the immmunohisto-
chemical detection of cytokeratin 7 and 13 (Fig. 1g, h).
SuperWcial low-grade tumours grew best in Epilife Medium
supplemented with bovine pituitary extracts, 1% FBS,
growth factors and non-essential amino acids (Table 1).
Coating of the Xasks with culture matrix and supplementing
the culture medium with 3 mM glycine dramatically
enhanced tumour cell growth. Cell viability analysis dem-
onstrated a 3.6-fold higher growth rate compared to con-
trols cultured in medium without glycine. Furthermore,
adding 1% supernatant of bladder Wbroblast cultures and
simulating hypoxic conditions by using 20 ml instead of
10 ml medium resulted in a remarkable better growth rate
(data not shown). Under these conditions, up to three pas-
sages of superWcial low-grade UC cultures were possible.
Across all stages and grades, the success rate of primary
cell cultures was 63%, but the technique appeared not
equally well suited for tumours of all grades and stages
(Table 2). In particular, tumour cells from superWcial low-
grade UC (pTa) could be cultured in 86.4% of the cases,
whereas only 50% of invasive pT1 and 38% of advanced
stage (¸pT2) tumours showed suYcient tumour cell growth
in vitro (P = 0.004). A major reason preventing establish-
ment of cultures from advanced stage tumours was that
tumours cells did not detach from the surrounding stroma
during overnight treatment by EDTA in 6 of 16 tumours.
Interestingly, tumours graded as G1 grew signiWcantly bet-
ter than G2 or G3 tumours when the new technique was
used (Table 2). There was good correlation between culture
success and tumour stage (P = 0.006) and grade (G1 + G2
versus G3 P = 0.034).
In 34% of the initially successful primary cultures, a sat-
isfactory passage was not possible (Table 2). However,
after optimisation of medium and substrate conditions,
almost all cultures of superWcial low-grade UC grew to the
point of possible passage.
Chromosome banding analysis clearly demonstrated the
malignant origin of the cultured cells showing an abnormal
karyotype in all metaphases analysed. At Wrst passage of a
pT1G2 tumour culture, an isochromosome i(5)(p10) and
loss of an entire chromosome 9 were observed. In later pas-
sages, the abnormal karyotype was duplicated and addi-
tional clonal aberrations occurred (Fig. 2).
Discussion
Most studies analysing superWcial low-grade UC used ani-
mal models, cancer cell lines or short-term cultures of tis-
sue specimens. Because there are speciWc diVerences
between rodent and human UC [23], Wndings from animal
studies are of limited evidence for the understanding and
therapy of human UC. Most human bladder cancer cell
lines are aneuploid and display genetic and molecular alter-
ations comparable to those in advanced UC [7–10]. This
may partly be due to a requirement for overcoming senes-
cence by inactivation of the RB1 or CDKN2A/p16 genes
[24]. To date, all permanent cell lines derived from low-
grade UC possess one or more of these alterations, limiting
their value for studying superWcial UC. Several groups
investigated short-term cultures of UC derived from tumour
tissue pieces [12–15] or urinary exfoliated cells [16, 17].
The majority of these studies cultured tumour explants
from advanced bladder cancer, which exhibit a high-take
rate in culture due to their high degree of growth autonomy.
However, primary cultures of low-grade superWcial bladder
cancer are much more diYcult to establish. Only a few
investigators were able to perform cultures of low-grade
superWcial UC over periods ranging from a few hours to
several days [13]. Due to the very short time frame of the
culture systems used, it remained unclear whether the cells
were still viable or able to proliferate, making the results
hard to interpret. Primary cultures of exfoliated cells from
spontaneously voided urine of patients with bladder cancer
or washouts during transurethral resections have apparently
been established more successfully [16, 17], but the cul-
tures were not well characterised and may contain variable
cell admixtures. Three-dimensional culture systems for UC
have been reported recently [12], which might be superior
to monolayer cultures in evaluating sensitivity to chemo-
therapeutics. However, the spheroids investigated con-
tained variable cell admixtures as well, so that further
development and validation of this in vitro model seem to
be advisable.
Table 2 InXuence of tumour grade and stage on success of primary
culture and passage
*P = 0.004
**G1 + G2 versus G3 P = 0.034
n Successful 
culture n (%)
Successful 
passage n (%)
pTa 22 19 (86.4)* 12/19 (63)
pT1 8 4 (50) 2/4 (50)
¸pT2 16 6 (38) 5/6 (83)
Total (%) 46 29 (63) 19/29 (66)
G1 7 6 (86)** 5/6 (83)
G2 22 16 (72)** 15/16 (94)
G3 17 7 (41) 4/7 (57)
Total (%) 46 29 (63) 19/29 (66)123
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cessful culture of superWcial low-grade UC of the bladder
under almost serum-free conditions and low-calcium con-
centration. The rationale for developing this culture system
was the assumption that the growth requirements of superW-
cial low-grade UC resemble those of normal urothelial
cells, rather than those of advanced cancers [18]. Based on
the supplemented keratinocyte serum-free medium as
described by Southgate et al. [19], modiWcations for suc-
cessful growth of superWcial UC were developed. Precoat-
ing the culture Xasks with extracellular matrix resulted in a
higher growth rate and signiWcantly better attachment of the
cells. This is in agreement with previous Wndings address-
ing culture conditions for epithelial tissue [25]. In addition,
it is known that bladder cancer cells are adapted to a hyp-
oxic environment [26]. Simulating more hypoxic growth
conditions in our culture system by using more medium per
culture Xask resulted in a higher growth rate of the tumour
cells. Another important step was the addition of glycine to
the culture medium. Glycine can promote integrin-medi-
ated cell adhesion [27], and it is particularly protective
against hypoxia/reoxygenation [28], which is a typical
exposure during cell culture. Before we used glycine as a
medium supplement, establishing the Wrst passage of the
tumour cells was evidently more diYcult. Growth and sur-
vival of urothelial carcinoma cultures were also improved
by addition of Wbroblast-conditioned media. This is in
accord with the idea that normal urothelial cells are induced
largely by autocrine mechanisms to proliferate, but signiW-
cant support is given by paracrine factors from the mesen-
chyme, especially FGF7/KGF [29].
To our surprise, the success rate for establishing cultures
from advanced UC using our culture technique was low. A
reason for this phenomenon could be that tumour cells from
EDTA-treated papillary tumour pieces detached more eas-
ily from the surrounding tissue than those from invasive
UC. The latter might be more deeply imbedded in the tissue
and extracellular matrix in particular. Moreover, the bad
success rate supports our previous Wndings suggesting fun-
damental diVerences in the tumour growth of invasive ver-
sus superWcial UC [18].
The culture system described may be helpful for testing
chemotherapeutics and for functional studies about tumour
biology. In the future, it may provide a tool to determine
individualised therapy approaches for patients with superW-
cial UC.
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